CEO Vuong Trieu presented at LD Micro conference on Oct 21; specifics not disclosed in filing

Oncotelic Therapeutics, Inc.

CEO Vuong Trieu presented a corporate presentation at LD Micro in San Diego on October 21, 2025.
Exhibit 99.1 containing the presentation is attached but its content was not reproduced in this filing.
No financial results, clinical updates, or guidance changes were provided in the 8-K text.
This is a procedural 8.01 announcement of an investor presentation; no material operational detail.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.